Year Book of Medicine 2020 Gurpreet S Wander
INDEX
Page numbers followed by f refer to figure, and t refer to table.
A
ABC care bundle 285, 286
Abiraterone 198, 199
Abortion
risk factor for 92
spontaneous 211, 217
Achalasia
cardia 149
idiopathic 149
symptoms of 149
Aches 293
nonspecific 121
Achondroplasia 228, 229
treatment of 228
Acinetobacter baumannii 75, 76
Acquired immunodeficiency syndrome 195, 196
Acute coronary syndrome 31
Acute exacerbations, development of 55
Acute migraine 303
therapy 299
treatments 300
Adalimumab 159, 160
plus methotrexate 322
Addisonian crisis 89
Adenoma, pituitary 85
Adenosine
monophosphate-activated protein kinase 112
triphosphate 28
Adjunctive intermittent pneumatic compression 36
Adrenal crisis 89
management of 89
Adrenal insufficiency 90
Adrenocorticotropic hormone 89
deficiency 85
Advanced fibrosis, development of 137
Advanced glycation end products 190, 191
ligands of receptors of 190
Adverse drug reactions 337
Aedes aegypti 168
Air pollution
ambient particulate 231
household 53
indoor 52, 53
Airway
disease 52
eosinophil, role of 57
Alanine aminotransferase 137, 185
Albiglutide 87
Aldosterone blocker 17
Alirocumab 100
safety of 99
Alkaline phosphatase 176
Allopurinol 330, 331
Alpha-glucosidase inhibitors 106, 108
Aluminum hydroxide 98
American Association of Clinical Endocrinologists 109
American College of Cardiology 35
American College of Rheumatology 323
American Heart Association 35, 289
American Stroke Association 289
Aminoglycoside 179
Amiodarone 99
Ammonia 134, 134f, 135
levels 134
prognostic role of 133
role of 134
Androgen
deprivation therapy 199
signaling-targeted inhibitors 198, 199
Anemia 25, 26, 206, 236, 268
chronic 26
correction of 268
prevalence of 206
Angiotensin-converting enzyme 17, 35, 239
blockade 255
inhibitors 22, 245
Angiotensin-receptor
blocker 17, 27, 245
neprilysin inhibitor 16, 17, 20, 43, 44
Anifrolumab 314, 315
Anorexia 121, 175
Antiarrhythmic agents 98
Antibiotics prophylaxis 38, 212
Antibodies, myositis-associated 279
Anti-citrullinated peptide antibody 321
Anti-diabetic
agents 107, 111, 112t
drugs 111, 112, 307, 308
Antineoplastic agents 98
Antineutrophil cytoplasmic antibody-associated vasculitis 341
treatment of 340
Antinuclear antibody 334, 335
test 334
Antiphospholipid 317
Antiplatelet agent 37
Antiretroviral
therapy 176
treatment 196
Antithrombotic therapy 31
Antithyroid peroxidase antibody 91
Anti-tubercular
therapy 145, 146
treatment 190, 191
Anti-tumor necrosis factor 151, 160, 337
Aortic stenosis 15
Apalutamide 199
Apixaban 32
dose of 32
Apnea-hypopnea index 72, 73
Apoplexy, pituitary 86
Arbovirus 293
encephalitides 293
Arcus cornealis 40
Arrhythmias 72, 74
atrial 74
cardiac 97
nocturnal 74
Arterial ammonia 134
Artery hypertension, pulmonary 72
Arthritis 324
inflammatory 331
psoriatic 324, 338
Arthropod-borne virus 293
Artificial intelligence 271, 272
Ascites 140
Aspartate aminotransferase 137, 185
Aspirations, bronchial 189
Aspirin 31, 32, 37, 135, 137, 155
therapy 136
Asthma 67
bronchial 52, 53
controlled 60
mild 58, 59
moderate 58
severe bronchial 105
treatment of 59, 60
uncontrolled 59, 60
Atherosclerosis, cerebrovascular 72
Atherosclerotic cardiovascular disease 12, 92, 100
At-home mortality
causes of 162f
rate 162
Atorvastatin 325, 326
Atrasentan 237, 238f, 239
Atrial fibrillation 13, 16, 18, 19, 31, 32, 73, 74
incidence of 13
recent-onset 14
Autoimmune rheumatic diseases, chronic 337
Autonomic nervous system dysfunction 328
Azathioprine 341
B
Back pain 121
Bacteremias 39
Balloon
expandable valve 15
mitral valvotomy 42
valvuloplasty 41
Bedaquiline 184
treatment, outcomes of 183
Bempedoic acid 29
Beta-agonist
long-acting 5860
short-acting 58, 59
Beta-blockers 32, 139
Beta-thalassemia 1
Bicarbonate 249f
Bile acid 98
Biliary obstruction, malignant 126
Biopsy-proven fibrosis 148
Biotin 99
Biventricular assist device 34
Bladder cancer, risk of 113
Blood
calcium 97
glucose 289
self-monitoring of 106
loss, hemodialysis-associated 236
pressure
control 282
systolic 89, 253, 281, 282
stream 249f
Body mass index 119, 181, 234
Body weight 88f
Bone
fracture 156
morphogenetic protein 2 333
Bordetella pertussis 68
Bowel disease, inflammatory 154
Brachial neuritis 299
Brain fog 97
Breast cancer 6
British Isles Lupus Assessment Group-based Composite Lupus Assessment 315
Bronchial arterial embolization 63, 63t, 64
Bronchiectasis 66, 67f
Bronchitis, allergic 170
Bronchoalveolar lavage 189
Bronchoscope, conventional 79
Brown-colored pigment lipofuscin 200
Brucella disease 181
Brucellosis 179, 180
gene polymorphisms of 180
Bruton's tyrosine kinase inhibitors 309, 310
development of 309
Budesonide-formoterol reliever therapy 58
C
Cabazitaxel 198, 199
Calcineurin inhibitors 256
Calcitonin 121
gene-related peptide 287, 302, 303
antagonists 303
pathway 300
Calcitriol 306
levels 121
Calcium
carbonate 98
sensing receptor 97
Campylobacter jejuni 168
Canagliflozin 93, 113, 239, 240
Cancer 105, 111, 142
death 23
development, risk of 111
disease 112
Carbidopa 304
Carbohydrate, high 104
Carbon monoxide, diffusing capacity of 54
Carcinoma, hepatocellular 136
Cardiac 18-fluorodeoxyglucose 327
Cardiac failure 329
advanced 156
Cardiac surgery 25
Cardiomyopathy
dilated 21
non-ischemic 328
Cardiovascular autonomic dysfunction 327
Cardiovascular disease 55, 74, 95, 114, 115, 142, 208, 227, 232, 233, 326328
prevention of 93
risk of 95, 227
Cardiovascular risk
factors 207, 208
reduction 12
Carotid intima media thickness 262, 263
Case fatality rate 203
Cataract 97
Catastrophic aortic rupture 27
Catecholamine support 29
Catechol-o-methyl transferase inhibitors 304
Ceftaroline 194, 195
Centers for Disease Control and Prevention 1
Central nervous system 296, 299
primary angiitis of 296
vasculitis, primary 297
Cerebrospinal fluid 189, 283, 284, 292, 293, 298
paucity of 177
Cerebrovascular accident 16, 30
risk for 16
Cesarean section, emergency 216
Chest X-ray 173
Childhood nephrotic syndrome 260
Chlorambucil 256
Cholangiopancreatography, endoscopic retrograde 126
Cholecystectomy 130
group 131
open 131
Cholesterol 12, 40
high 40
low 306
Chronic obstructive pulmonary disease 46, 50, 54, 55f, 56, 67, 75, 76, 170
acute exacerbation of 56
assessment of 54
Chronic pulmonary disorders 46
Chronic respiratory diseases questionnaire 45
Ciprofloxacin 170
Cirrhosis 133, 137, 156
Cirrhotic population 134
Classic fever of unknown origin 175
etiology of 174
Clinical disease activity index 322
Clostridium difficile infection 155, 156
Coenzyme Q10 306, 307
Combined hormonal contraceptives, use of 317
Complete blood count 328
Computed tomography 327, 330
Connective tissue disease 47, 317, 335, 336
Constipation 121
Continuous positive airway pressure 72
Contraception 318
methods 317
Contrast-enhanced pulmonary angiography 78
Copper displacement therapy 217
Cord accidents 216
Coronary angiography after cardiac arrest 29
Coronary artery bypass grafting 6, 10, 11, 30, 32, 36
surgery 122
Coronary artery disease 5, 6, 13, 30, 35, 40, 287, 302, 329
management of 11
Coronary revascularizations 23
Corticosteroids 297
chronic inhaled 66
free remission 160
therapy 144
Cough 175
COVID-19 35, 77
complication of 77
infection 77
vaccine 36
C-reactive protein 176
Creatinine
higher values of 185
serum 97
Crohn's disease 153, 154
Cryptococcal meningitis 176, 177
Cryptococcus neoformans 177
Cryptococcus-associated immune reconstitution inflammatory syndrome 176, 177
Crystalloids, balanced 70
C-type natriuretic peptide 228, 229
recombinant 229
Cyclophosphamide 256, 297, 340, 341
Cyclosporine 255, 255f, 324
Cystatin C 267
Cysticercus, evolution of 295f
Cytokines 180, 303
abnormalities 334
interleukin 334
role of 180
Cytomegalovirus 293
D
Dactylitis 324
Daily living, activities of 206
Dalfopristin 195
Dapagliflozin 113
Daptomycin 195
Death
AIDS-related 197
cardiovascular 35, 92
non-AIDS-related 197
prognostic indicators of 185
Deep vein thrombosis 36, 37, 78
Dehydration 106t, 121
risk of 106
Dehydroepiandrosterone sulfate 181, 182
Delirium 302
Dementia 156
Dengue
associated acute encephalitis syndrome 292
encephalitis 292, 293
encephalopathy 292
maculopathy 292
neutralizing antibodies 168
virus 292
serotype 2 168
Deoxyribonucleic acid 180
mitochondrial 55
Dermatomyositis 47
Destination therapy 33
Diabetes
control and complications trial 95
insipidus, central 86
mellitus 5, 82, 111, 190, 241, 302
absence of 11
complications, management of 105, 106t
management of 104
status of 20
type 1 91, 105, 111
type 2 19, 20, 82, 83, 86, 87, 92, 102, 103, 105, 111, 239, 240, 273, 276
Diabetic kidney disease 238, 238f, 240, 273
development of 273
progression of 273
treatment of 240
Diabetic retinopathy, pre-existing 88
Diarrhea 52, 90, 242, 313
Difelikefalin 243
uremic pruritus 243t
Digital subtraction angiography 296, 297
Dimethyl fumarate 309
Dipeptidyl peptidase-4 108
Disease activity score 324
Disease-modifying anti-rheumatic drugs 313, 318, 320, 321, 323, 324, 327, 337, 338
Dizziness 242
Docetaxel 199
Dolutegravir 164166
Dor's fundoplication 149
Double-blind 26, 59, 139
Double-stranded deoxyribonucleic acid 316
Drug profile 165
Drug-resistant
mutations, prevalence of 165
tuberculosis 61, 62
Dry skin 101
Dual-energy X-ray absorptiometry 244
Dulaglutide 87
Dwarfism phenotype 229
Dyslipidemia 30, 40, 100
Dyspnea 46, 175
Dysthyroid 102
E
Ebola virus 185
disease 184, 185
therapeutics 185
Echocardiographic score 41
Eclampsia 216
Ectopia lentis 221
Ectopic calcification 121
Eczema 200
Edema
inflammatory 295f
intermittent perilesional 294
Efavirenz 165
Ejection fraction, reduced 44
Electrocardiogram 328
Electronic health record 271
Electrophysiological tests 284
Empagliflozin 93
Emphysema 55
Enamel hypoplasia 97
Encephalitis 299
Encephalomyelitis, acute disseminated 292
Encephalopathy 140
Endobronchial ultrasound 79
Endocarditis, risk of 38
Endoscopic drainage 130
Endoscopic ultrasound 127
guided transmural approach 126
Eneligliptin 103
Enterococcus faecalis 194
Enterocytes 148
Enthesitis 324
Enzalutamide 198, 199
Enzyme, aminoglycoside-modifying 179
Enzyme-linked immunosorbent assay 167, 172, 177, 180, 293, 335
Eosinopenia 56
Epilepsy 308
Epstein–Barr virus 293
Erythrocyte sedimentation rate 176, 324, 328
Erythropoiesis-stimulating agents 235, 236, 268, 270
Erythropoietin 306
subcutaneous 26
Escherichia coli 179, 186, 187
Esophageal hypersensitivity 158
Established status epilepticus treatment trial 290, 291
Estimated glomerular filtration rate 234, 239, 240, 243, 245, 247, 274t, 276, 340
Estradiol 182
serum 182
Estrogen 318
containing drugs 98
levels of 214
Etravirine 278
European League Against Rheumatism 279
Evolocumab 100
safety of 99
Exacerbation, pulmonary 170t
Exclusive enteral nutrition 154
Exercise 106
Expanded disability status scale 309
Extensively drug-resistant tuberculosis 183
External trigeminal neurostimulation 299, 300
Extracorporeal membrane oxygenation 34
Extrapulmonary tuberculosis 62
diagnosis of 188
Eye 40
disorder, inherited 221
F
Fall, fear of 201
Familial hypercholesterolemia 39, 40, 227, 228f
prevalence of 39
Fasting blood sugar 119
Fatigue 46, 101, 121
Fatty acids 5
Fatty liver disease, nonalcoholic 135, 137, 138f, 147, 148
Febrile illness, acute 293
Febuxostat 330, 331
Fecal microbiota transplantation 151
role of 150
use of 7
Ferrous sulphate 98
Fervenza 255
Fetal distress 216
Fever 90, 175
Fever of unknown origin 174, 175
etiology of 175f
neutropenic 175
nosocomial 175
types of 175
Fibroblast growth factor 233
Fibrosis 45, 137
progression, risk for 135
Flavivirus 4, 292
Fluorodeoxyglucose positron emission tomography 327
Focus-reduction neutralization test 293
Fondaparinux 37
Forced vital capacity 4648, 51, 312, 313
Formoterol fumarate 60
Fosphenytoin 291
intravenous 291
FR nephrotic syndrome 257
Frequent blood glucose monitoring 106
Fridericia's formula 65
Friedreich's ataxia 277, 278
genetic basis of 278
G
Gallstones 130, 131
pancreatitis, mild 130, 131
Gastric
aspirates 68
atrophy 156
Gastroenterology 126
Gastroesophageal reflux 149
disease 151, 152, 157
Gastrointestinal malignancies 156
Gastrointestinal symptoms 1, 89
Gastrointestinal tract 236, 301
Gene 1
therapy 1
Genetic testing, clinical utility of 221
GeneXpert 190
evaluation of 188
Mycobacterium tuberculosis 188, 189
performance of 188
Genital fungal infections 93
Genome-wide association studies 55
Geriatric
dermatology 200
dermatoses 200
population 101, 201
Gestational diabetes mellitus, prevalence of 219, 220
Gliclazide 105, 108, 120
Glimepiride 108, 120
Glomerular filtration rate 71, 244, 249, 251, 266
Glucagon-like peptide 87, 112
Glucocerebrosidase 223
Glucocorticoid 85, 321
Glucose-6-phosphate-dehydrogenase 2
Glucuronoxylomannan 176, 177
Glycemic durability 82
Glycopeptidolipid 182
Gout 331
Granulomatosis 329
eosinophilic 329
Graves’ disease 99
Growth hormone deficiency 85, 86
Guillain–Barré syndrome 168, 283, 284, 292, 299
spectrum of 284
H
H1N1 162, 173
influenza 173
Haemophilus influenzae 68, 69
Health assessment questionnaire 324
Heart 326
disease, congenital 38
failure 1922, 34, 35, 37, 43, 73, 92, 239, 329
acute decompensated 16
chronic congestive 17, 35
Heartburn, refractory 157
Helicobacter pylori 152
infection 152
Heller's myotomy 149
laparoscopic 149
Hemodiafiltration 262
Hemodialysis 263
conventional 262
Hemoglobin
glycated 82, 88f, 95
glycosylated 103
reticulocyte 26
Hemoptysis
management of tuberculosis-related 63
massive 63
Hemorrhage
acute
cerebral 285
intracerebral 280, 285
Heparin, unfractionated 37
Hepatic dysfunction 105
Hepatic encephalopathy 144
pathogenesis of 133
Hepatic failure, severe 293
Hepatic impairment 103
Hepatic venous pressure gradient 139, 140
Hepatitis
autoimmune 144
B
chronic 136, 137
virus 145
C, treatment of 99
E virus infection 213, 214
Hepatocytes 148
Hepatology 126
Hepatotoxicity 204
Hernias, incisional 129
Herpes
simplex encephalitis 293
virus 293
Heterogeneity 131
High blood eosinophil counts 56
Highly active antiretroviral therapy 197
High-resolution computed tomography 47, 50
Hodgkin's lymphoma 176
Human chorionic gonadotropin 85, 92, 214
Human immunodeficiency virus 65, 69, 165, 176, 177, 196
infection 62, 68, 184, 195
Human leukocyte antigen 247
Human metapneumovirus 68
Human monoclonal antibody 314
Human papillomavirus 167, 167f
vaccination schedules 166
Human parainfluenza virus 68
Human rhinoviruses 162
Hydrochloric acid 249f
Hypercalcemia, mechanism of 121
Hypercholesterolemia 204
heterozygous familial 28
Hyperglycemia 106t, 110, 288, 289
management of 83
Hyperphosphatemia 97
management of 233
Hypertension 7, 72, 233, 282, 302, 317
complications of 253
portal 139
resistant 245
uncontrolled 253, 287
Hyperthyroidism, iatrogenic 102
Hypertriglyceridemia 12
Hypervitaminosis D 121
Hypoalbuminemia 302
Hypocalcemia 97
Hypodontia 97
Hypoglycemia 104, 106t, 110, 288
risk of 106
Hypogonadism, central 85, 86
Hypoparathyroidism 96
clinical features of 97
diagnosis of 97
Hypopituitarism 85
management of 85
Hypotension, risk of 106
Hypothalamus 85
Hypothyroidism 91
Hypovitaminosis D 121
Hypoxemia 74
Hypoxia 269
I
Idiopathic pulmonary fibrosis 46, 4851, 313
antifibrotic medications for 48
management 50f
Immunodeficiency syndrome, primary 1
Immunoglobulin M 293
Immunology 311
Immunosuppression 119, 156
Impella 34
Incretin mimetics 113
Indian Society of Gastroenterology 152
Infarction, myocardial 30, 32, 39, 92, 156, 240
Infections 175, 338
source of 34
Infectious diseases 66, 161
Infective endocarditis 38, 39
prevention of 38
Inferior vena cava 37
Infertility, risk factor for 92
Inflammation
myocardial 327
progressive 45
Inflammatory disease, noninfectious 175, 176
Inflammatory myopathies, idiopathic 279
Infliximab 160
Influenza
A 162
H1N1 strain of 173
infection 35
vaccination 34, 35
vaccine 34
prophylactic 35
virus 68
Infusion, intravenous 89
Inhaled corticosteroids 60, 66, 67f
role of 56
Inhaled liposomal ciprofloxacin 169
Injury, myocardial 29
Insomnia 74
Insulin 111113
adoption of 109
coformulations 110
like growth factor
binding protein 266, 267
type 1 receptor 112, 263
long-acting 108
premixed 108
resistance 119
secretagogues 111113
sensitizers 113
short-acting 108
therapy 109, 110f
treatment 111
Intensive blood pressure 282, 285
reduction 281
Intensive care unit 37, 76, 173, 301
Intensive coronary care unit 34
Intensive glucose control 94
Interferon
alfa 99
gamma release assay 338
Interleukin 5, 71, 181
gene polymorphisms of 180
International Study of Kidney Disease 260
Interstitial lung disease 45, 47, 48, 50, 312, 313, 333, 334
chronic 46
nonidiopathic pulmonary fibrosis 47f
progressive fibrosing 46
systemic sclerosis-associated 312
treatment of 51
types of 46
Interstitial pneumonia 47, 50
idiopathic nonspecific 47
Intracerebral hemorrhage 280, 282, 285
care bundle 285
spontaneous 280, 281, 285
Intravenous therapy 179
Intravenous thrombolysis therapy 281, 282
Iodine 98
Iron
deficiency 25, 26
intravenous 234
Ischemia, cardiovascular 72
Izbicki pain scores 129
J
Janus kinase 1 323
Japanese encephalitis 292, 293
virus 292
Jod-Basedow phenomenon 99
Joint 326
K
Kaplan–Meier
curves 117f
estimate 15, 21, 258f
Ketoacidosis, diabetic 106t
Kidney
disease 156
anemia of 236, 268
chronic 233, 236, 237, 242245, 248, 249, 251, 266, 268, 273
end-stage 237, 239
severe 93
function 272
functional role in 267
injury
acute 29, 71, 266, 267t, 270, 271
marker-1 267
transplants 246
volume, total 251, 252
Klebsiella pneumoniae 76
Knee osteoarthritis 121
L
Lactic acidosis, metformin-associated 123
Lanthanum carbonate 233
Lasmiditan 286, 287
Lassa
fever 171
virus 171, 172
Leflunomide 324
Left main coronary artery disease 10
Left ventricular
assist device 33
end-diastolic volume 21
mass index 262
ejection fraction 21, 22
Legionella pneumophila 163
whole-genome sequences of 163
Legionnaire's disease 163
Leukopenia 293
Levamisole 257, 258f
Levodopa 304
Levothyroxine 91
treatment 102
Linezolid 194, 195
Lipoprotein 8
cholesterol 333
high-density 40, 142
intermittent density 40
low-density 12, 24, 100, 227, 307
Liposomal ciprofloxacin 170
Liraglutide 87
Lithium 99
Liver
biopsies 135
disease
chronic 147, 173, 174, 174f
end-stage 143, 144, 146
model for end-stage 145
failure
acute 134, 146
acute-on-chronic 135, 143, 144, 146
chronic 134
drug-induced acute-on-chronic 143
function test 52
injury
causes of 145
drug-induced 145
transplantation 144, 146
type fatty acid binding protein 267
volume 251
total 251
Living donor liver transplantation 146
Low blood eosinophil counts 56
Low lupus disease activity state 316
Low serum estradiol levels 181
Low-density lipoprotein 12, 24, 100, 227, 307
cholesterol 23, 228f
role of 28
Low-molecular weight heparin 37
Lumen-apposing metal stents 127, 128
non-superiority of 127
Lung
disease, chronic 173
for carbon monoxide 48, 54
diffusing capacity of 47
function, development of 53
infection, chronic 169, 170
injury, E-cigarette use associated 1
Lupus low disease activity state 315
Lymph node 175
Lymphocyte trafficking inhibitor 160
M
Macrolides 66
monotherapy 67f
Magnetic resonance
angiography 297
imaging 294, 329
Maintenance budesonide plus terbutaline reliever therapy 58
Major adverse cardiovascular events 275, 276
Malaria 2, 192
control of 191
episodes, frequency distribution of 193f
ivermectin mass drug trial for control of 192
Mantoux test 338
Marfan's syndrome 26, 27, 221
treatment of 27
Mean arterial pressure 262
Measles 69
Mechanical ventilation 29, 76, 77
Membranous nephropathy 256
treatment of 255
Meningitis 299
Menopausal hormonal therapy 6
Menorrhagia 236
Mental disorders, perinatal 218
Meropenem 179
Metabolic acidosis 244, 248
neutralization of 243
saline-induced 71t
Metabolic disorders 82
Metabolic switch 142
Metalloproteinases, urinary tissue inhibitor of 266
Metformin 82, 83, 105, 107, 120, 122, 123, 123f, 275, 276
monotherapy 82, 276
plus 83
therapy 190
Methicillin 194
Methicillin-resistant Staphylococcus aureus 193, 194
Methotrexate 323325, 341
Micro ribonucleic acid 55
Micronutrient deficiencies 156
Migraine 287, 299, 302, 303
acute treatment of 286, 287
attacks 302
treatment of 300
Mineralocorticoid receptor antagonist 22
Ministry's Health National Minimum Dataset 220
Miscarriage 211
risk of 91
surgery 212
tissues, removal of 212
Mitogen-activated protein kinase 57, 229
Mitral stenosis, severe 42
Mitral valve
area 42
calcification 41
calcium assessment 41
replacement 42
Mitral valvotomy, closed 42
Molecular tests 189
Monoamine oxidase-B inhibitors 304
Monoclonal antibody 5
Mononeuritis 299
Mortality
AIDS-related 195
non-AIDS-related 195
Multidrug-resistant tuberculosis 65, 183
management of 3
Multiple sclerosis 309, 310
pathogenesis of 309
Multiplex deoxyribonucleic acid amplification test 189
Muscarinic agents, long-acting 60
Myalgias 292
Mycobacteria 189f
Mycobacterial infection, nontuberculous 182
Mycobacterium
avium complex lung disease 181, 182
tuberculosis 62, 68, 69, 188
Mycophenolate mofetil 257, 258, 258f, 313, 340, 341
Myeloperoxidase 340
Myocardial infarction, low-dose colchicine after 6
Myopathies, inflammatory 279
Myositis 279, 292, 299
Myotomy
endoscopic 149
surgical 149
N
N-acetyl cysteine 51
Naïve systemic sclerosis 333
Nasopharyngeal swabs 162
Nasopharyngitis 58
National Institutes of Health Stroke Scale 289, 296
National Tuberculosis Elimination Program 62
National Vector Borne Disease Control Program of India 292
Natriuretic peptide 44
Nausea 121
Necrosectomy, open 129
Necrosis, pancreatic 130
Neonatal intensive care unit 162
Neoplasms 176
Nephrology 233, 271
Nephropathy 239
Nephrotic syndrome 257, 259
Neprilysin 17
inhibition 17
Neurocysticercosis 294
calcified stage of 296
Neurology 277
Neutrophil gelatinase associated lipocalin 267
New-onset diabetes mellitus after transplantation 118, 119
Nicotinamide 233, 234
Nintedanib 50, 312, 313
Nissen fundoplication 158, 158t
Nodules 80
Noncommunicable diseases 4
Non-cystic fibrosis 66
bronchiectasis 169, 170
Non-Hodgkin's lymphoma 176
Non-rapid eye movement 74
Nonsteroidal anti-inflammatory drugs 135, 137
Nutrition 105
role of 4
O
Obeticholic acid 147, 148
Obstructive sleep apnea 72
Ocular anterior segment dysgenesis 221
Omega-3 fatty acids 274, 274t
supplementation 272274
Oocyte 92
Opsoclonus 298
myoclonus 299
scrub typhus-associated 298
Optic neuritis 292
Optimal medical therapy 11
Oral anticoagulants 32
newer 32, 37
Oral contraceptive 98
pills 318
Oral glucocorticoid hydrocortisone 85
Oral semaglutide 86, 87
Organ failure 134, 203
assessment 76
Orientia tsutsugamushi 298
Oritavancin 195
Osteoporosis 332
diagnosis of 332
P
Pains 293
chronic 311
musculoskeletal 175
Pancreatic necrosis, infected 130
Pancreatitis 121, 131
acute 129
chronic 129, 130
necrotizing 129
Pancreatoduodenectomy
laparoscopic 131133
open 131
Papilla 126
Parainfluenza virus 68
Parathyroid hormone 96, 97, 120
therapy 97
Parenchyma, pulmonary 64
Parkinson's disease 222, 224f, 301, 304306
genetics of 223
Pediatric cataracts 221
Pelvic infection 212, 213
risk of 212
Penicillin 194
Peptic ulcer, acute 105
Percutaneous coronary intervention 6, 10, 11, 29, 31, 36
role of 11
Percutaneous transvenous mitral commissurotomy 42
Peripheral nervous system manifestations 299
Peritonitis, spontaneous bacterial 156
Peroxisome proliferated activated receptor 112
Phosphate 97
serum 233
Phosphodiesterase 5 inhibitor 313
Pioglitazone 106, 107
Placebo-controlled trial 26, 91, 228, 309
Plasma
ammonia 134
antibody response 176, 177
Plasmodium
falciparum 2
vivax 2
malaria 2
Plastic stents 127
Plazomicin 178, 179
role of 178
Pneumocystis pneumonia 196
Pneumonia 68, 69, 90, 156, 170
severe 68
childhood 69
ventilator-associated 75
Pneumonitis, chronic hypersensitivity 47, 48
Polyangiitis 329
microscopic 329
Polycystic kidney disease, autosomal dominant 251
Polymerase chain reaction 69, 171, 180, 293
Polymyositis 47
Polyurea 121
Portal hypertension, clinically significant 140
Positive reverse transcriptase polymerase chain reaction 185
Positive tourniquet test 293
Positron emission tomography 176, 330
Post-mitotic cell 1
Postpartum depression 219
risk factors for 218
Postsurgery sepsis, prevention of 213
Prednisolone
therapy 261
treatment 261f
Preeclampsia 7
Premature coronary artery disease 39
prevalence of 39
Pro-enkephalin 267
Progesterone 210, 211, 214, 318
supplementation 211
Prostate
cancer 199
metastatic 198
transurethral resection of 37
Prosthetic valves 39
Proton pump inhibitors 98, 152, 155, 157, 158
safety of 155
Pruritus 200, 242
sensation of 242
Pseudomonas aeruginosa 75, 76, 169, 170
Psoriasis 324
Pulmonary embolism 78
diagnosis of 78
Pulmonary function test 47
Pulmonary rehabilitation 45
effect of 45
Puromycin resistance gene 226
Pyelonephritis, acute 265
Pyrexia 213
Q
Quinupristin 195
R
Radial endobronchial ultrasound 79
Raloxifene 98
Randomized controlled trial 131, 140, 156, 169, 170, 236, 238, 246, 247, 256, 299, 331
Rankin scale, modified 280, 281, 283
Rapamycin, mammalian target of 142
Rapid drug susceptibility test 4
Rapid eye movement 74
Rash 293
Reactive oxygen species 112
Red blood cell transfusion 26
Refractory epilepsy 307
Renal denervation 252254, 254f
Renal disease
end-stage 237, 241, 248, 251
progression of 92, 93
Renal dysfunction 135
Renal failure
advanced 156
severe 293
Renal function 71
Renal replacement therapy 70, 267
Renal transplant recipients 118
Renin–angiotensin
aldosterone
pathway 245
system 17
system 238, 240
Respiratory diseases 53, 204, 232
allergic 52
history of 53
Respiratory dysfunction 135
Respiratory failure 51, 77
acute 76
severe 293
Respiratory illness, severe acute 77
Respiratory infection, acute 161, 162
Respiratory syncytial virus 68, 162
Restenosis 41
Resuscitation, cardiopulmonary 30
Retinal disease, inherited 221
Reverse transcriptase polymerase chain reaction assays 172, 184
Revised National Tuberculosis Control Program 62
Rheumatic diseases 311, 339
autoimmune 337
immune-mediated 336
Rheumatoid arthritis 47, 310, 318327, 329, 338
management of 323
Rheumatoid factor 321
Rheumatology 311, 339
Rhinitis, allergic 52, 53
Ribonucleic acid 184, 293
noncoding 55
Rifampicin 188
Rifampin-resistant tuberculosis 64
Right ventricle dysfunction 34
Right ventricular assist device 34
Ringer's lactate 71
Rituximab 255, 255f, 256, 341
Rivaroxaban 155
testing of 32
S
Sacubitril 17, 43, 44
Sarcoidosis, chronic 47
Scleroderma 313
lung study 313
Sclerosis, systemic 47, 313, 333, 334
Scrub typhus 298, 299
neurological manifestations of 299t
neurology of 298
Seizures, convulsive 293
Semaglutide 87
Sepsis 204
causes of 203
syndrome 77
Sex hormones, serum levels of 182t
Shock, markers of 29
Single inhaler extrafine triple therapy 59
Sinus rhythm, normal 14
Six gene therapy products 1
Sjögren's syndrome 336
Skin disease 324
Sleep 72
apnea severity 73
normal 74
Small intestinal bacterial overgrowth 156
Society for Thoracic Surgery 15
Sodium
bicarbonate 243, 244
glucose cotransporter-2 19, 20, 106, 108, 116, 117
inhibitors 93, 116, 241
Solitary cysticercus granuloma 294
Spinal muscular atrophy 1
Spironolactone 17
Sputum 189
Staphylococcus aureus 69, 193, 194
resistance, timeline of 194t
Statins 227, 306
hepatic safety of 204
therapy 332
efficacy of 23
safety of 23
Status epilepticus 290
convulsive 290, 291f
Steatohepatitis, nonalcoholic 147, 148, 148f
Steroids 145
catabolism of 89
dose of 90
therapy 144
duration of 260
Streptococcus pneumoniae 69
Stress, post-traumatic 215
Striated muscle, inflammatory disease of 279
Stroke 5, 23, 72, 92
acute ischemic 281, 288, 289
composite of 15
hyperglycemia insulin network effort 289
ST-segment elevation myocardial infarction 29, 30
Sucralfate 98
Sulfonylureas 107, 108, 275
Sulphasalazine 324
Swollen joint count 322
Sympathetic nervous system, activation of 17
Synthetic pentasaccharide 37
Systemic lupus erythematosus 310, 314317, 329, 334, 335, 338
pathogenesis of 314
treatment of 314
T
Tachycardia, ventricular 29, 30
Tacrolimus 119
Taenia solium 294
Tafenoquine 3
Takayasu arteritis 329
Tedizolid 195
Telavancin 195
Tendon xanthomata 40
Teneligliptin 102, 103
Testosterone, serum 181
Therapeutic gene 1
Therosclerotic cardiovascular disease 28
Thiazolidinediones 112, 113
Thoracoabdominal replacement 33
Thrombocytopenia 293
Thromboembolism
pulmonary 37
venous 37, 78
Thromboprophylaxis
pharmacologic 36
venous 36
Thyroid
antibodies 92
autoimmunity 91
conception 90
disease, autoimmune 99
disorder 101, 102
dysfunction 99
severe 98
function 90, 98
test 91, 101
gland 99
hormone 89, 99, 102
exogenous 99
nodule 99
peroxidase antibodies 91
stimulating hormone 90, 99
deficiency 85
Thyroiditis, destructive 99
Thyrotoxicosis 99
Thyrotropin concentration 102
Thyroxin 85, 98
dissolution of 98
dose of 98
Tick-borne infectious disorder 298
Tiotropium 60
Tissue
damage 203
hypoxia 206
Transcatheter aortic valve replacement 15
Transforming growth factor 27, 334
Triglycerides 40, 141
Triple vessel disease 6
Tuberculosis 61, 170, 175, 183, 189, 190, 196, 337, 338
control 62
diabetes comorbidity 190
pulmonary 105
Tubular necrosis, acute 266
Tumor
necrosis factor 180, 181, 328
alpha 180, 303
inhibitor 318
pancreatic 131
periampullary 131
Tyrosine kinases inhibitors 50, 323
U
Ulcerative colitis 5, 150, 151, 160
moderate-to-severe 6, 159
Ulfonylurea 103
Ultrasonography 176
Ultrathin bronchoscope 79, 80
Unified Parkinson's disease rating scale 305
Upadacitinib 323
Uremic pruritus 242, 243
treatment of 242
Urinary tract infection 117, 178, 264, 265t, 302
severe 116, 117f
Ustekinumab 5
Uterine
rupture 216
tenderness 213
V
Vaginal discharge, purulent 213
Valsartan 17, 43, 44
therapy 17
Vancomycin 194
resistant
Enterococcus 194
Staphylococcus aureus 193195, 195t
Variceal bleeding 139, 140
Vascular disease 23, 95
peripheral 73
pulmonary 78
Vasculitis 338, 341
Vedolizumab 159, 160
Vesicoureteral reflux 264
primary 264, 265t
Veterans affairs diabetes trial 95
Veverimer 248, 249, 249f
Vildagliptin 82, 83
Viral infections 214
Viral load 165
Visual analog scale 299
Vitamin 26
deficiency 121
dose of 121
effect of 272
intoxication 121
toxicity 120, 121
D3 2, 121
insufficiency 274
supplementation of 273
E 148
K antagonist 31, 32
Voiding cystourethrogram 264, 265
Volatile organic compounds 53
Vomiting 121, 242
W
Walled-off necrosis drainage 127, 128
Warfarin 32
Weight loss 175
Whipple's surgery 133
Wilson disease 217
Wolff–Chaikoff effect 99
World Health Organization 52, 183, 218, 231
Worst itching intensity numerical rating scale 242, 243
X
Xerosis 200
Y
Yoga 105
Z
Zika virus 168
Zoledronic acid 121, 215
×
Chapter Notes

Save Clear


fm1Year Book of MEDICINE 2020fm2
fm3Year Book of MEDICINE 2020
Chief Editor Gurpreet S Wander MD DM Professor and Head Department of Cardiology Hero DMC Heart Institute Dayanand Medical College and Hospital Ludhiana, Punjab, India Section Editors Siddharth N Shah Surinder K Jindal VK Bahl Ajay Kumar Vivekanand Jha R Rajasekar Rohini Handa Jyotirmoy Pal Gagandeep Singh Foreword Siddharth N Shah YP Munjal
fm4
Jaypee Brothers Medical Publishers (P) Ltd
Headquarter
Jaypee Brothers Medical Publishers (P) Ltd
4838/24, Ansari Road, Daryaganj
New Delhi 110 002, India
Phone: +91-11-43574357
Fax: +91-11-43574314
Overseas Office
J.P. Medical Ltd
83 Victoria Street, London
SW1H 0HW (UK)
Phone: +44 20 3170 8910
Fax: +44 (0)20 3008 6180
© 2020, Jaypee Brothers Medical Publishers
The views and opinions expressed in this book are solely those of the original contributor(s)/author(s) and do not necessarily represent those of editor(s) of the book.
All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission in writing of the publishers.
All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book.
Medical knowledge and practice change constantly. This book is designed to provide accurate, authoritative information about the subject matter in question. However, readers are advised to check the most current information available on procedures included and check information from the manufacturer of each product to be administered, to verify the recommended dose, formula, method and duration of administration, adverse effects and contraindications. It is the responsibility of the practitioner to take all appropriate safety precautions. Neither the publisher nor the author(s)/editor(s) assume any liability for any injury and/or damage to persons or property arising from or related to use of material in this book.
This book is sold on the understanding that the publisher is not engaged in providing professional medical services. If such advice or services are required, the services of a competent medical professional should be sought.
Every effort has been made where necessary to contact holders of copyright to obtain permission to reproduce copyright material. If any have been inadvertently overlooked, the publisher will be pleased to make the necessary arrangements at the first opportunity. The CD/DVD-ROM (if any) provided in the sealed envelope with this book is complimentary and free of cost. Not meant for sale.
Inquiries for bulk sales may be solicited at: jaypee@jaypeebrothers.com
Year Book of Medicine 2020
First Edition: 2020
9789390020683
Printed at
fm5Dedication
This book is dedicated to
Our parents; who taught us how to read
Our teachers; who taught us how to understand what we read
Our patients; who taught us how to use the knowledge we acquire by reading, for the benefit of humanity.fm6
fm7CONTRIBUTORS
Chief Editor
  • Gurpreet S Wander MD DM
  • Professor and Head
  • Department of Cardiology
  • Hero DMC Heart Institute
  • Dayanand Medical College and Hospital
  • Ludhiana, Punjab, India
Section Editors
  • Siddharth N Shah MD FACP (Hon) FRCP (Edin)
  • PG Teacher, University of Mumbai
  • Consultant, Bhatia, SL Raheja
  • Saifee, and Sir HN Reliance Hospitals
  • Mumbai, Maharashtra, India
  • Surinder K Jindal MD
  • Medical Director
  • Jindal Clinics
  • Emeritus-Professor
  • Postgraduate Institute of Medical
  • Education and Research
  • Chandigarh, India
  • VK Bahl MD DM
  • Principal Director
  • Max Health Care
  • Ex-Dean and Ex-Head
  • Department of Cardiology
  • All India Institute of Medical
  • Sciences
  • New Delhi, India
  • Ajay Kumar MD DM
  • Chairman
  • BLK Liver and Digestive Diseases
  • Institute
  • New Delhi, India
  • Vivekanand Jha MD DM
  • Executive Director
  • George Institute for Global Health
  • India, New Delhi, India
  • Chair of Global Kidney Health
  • Imperial College
  • London, United Kingdom
  • R Rajasekar MD
  • Senior Consultant Physician and
  • Diabetologist
  • Heart and
  • Diabetes Therapy Centre
  • Kumbakonam, Tamil Nadu, India
  • Rohini Handa MD DNB
  • Senior Consultant
  • Department of Rheumatology
  • Apollo Indraprastha Hospitals
  • New Delhi, India
  • Jyotirmoy Pal MD
  • Professor
  • Department of Medicine
  • RG Kar Medical College
  • Kolkata, West Bengal, India
  • Gagandeep Singh MD DM
  • Professor and Head
  • Department of Neurology
  • Dayanand Medical College and Hospital
  • Ludhiana, Punjab, Indiafm8
Associate Editors
  • Ragini Maheshwari MBBS
  • Consulting Diabetologist
  • Rohit Diabetes Centre and Seven Hills Hospital
  • Mumbai, Maharashtra, India
  • Naveen Mittal MD DM
  • Professor
  • Department of Endocrinology
  • Dayanand Medical College and Hospital
  • Ludhiana, Punjab, India
  • Aditya Jindal DNB DM
  • Senior Consultant and Interventionalist
  • Jindal Clinics
  • Chandigarh, India
  • Uma M Krishnaswamy MD DM
  • Professor and Head
  • Department of Pulmonary
  • Medicine
  • St. John's National Academy of Health Sciences
  • Bengaluru, Karnataka, India
  • Uma Devaraj MBBS DNB
  • Professor
  • Department of Pulmonary
  • Medicine
  • St. John's National Academy of Health Sciences
  • Bengaluru, Karnataka, India
  • Kavitha V MD DM
  • Assistant Professor
  • Department of Pulmonary
  • Medicine
  • St. John's National Academy of Health Sciences
  • Bengaluru, Karnataka, India
  • Gurpreet S Wander MD DM
  • Professor and Head
  • Department of Cardiology
  • Hero DMC Heart Institute
  • Dayanand Medical College and Hospital
  • Ludhiana, Punjab, India
  • Tiny Nair MD DM
  • Professor and Head
  • Department of Cardiology
  • PRS Hospital
  • Thiruvananthapuram, Kerala, India
  • Dinkar Bhasin MD DM
  • Assistant Professor
  • Department of Cardiology
  • Vardhman Mahavir Medical
  • College and Safdarjung Hospital
  • New Delhi, India
  • Sandeep Lakhtakia MD DM
  • Director - Endoscopy & EUS
  • Asian Institute of Gastroenterology
  • Hyderabad, Telangana, India
  • Manav Wadhawan MD DM
  • Director
  • BLK Institute of Digestive and Liver
  • Diseases
  • New Delhi, India
  • Vineet Ahuja MD DM
  • Professor
  • Department of Gastroenterology and Human Nutrition
  • All India Institute of Medical Sciences
  • New Delhi, India
  • Gopesh K Modi MD DM
  • Consultant
  • Department of Nephrology
  • Noble Samarpan Kidney Centre
  • Bhopal, Madhya Pradesh, India
  • Joyita Bharati MD DM
  • Assistant Professor
  • Department of Nephrology
  • Postgraduate Institute of Medical
  • Education and Research
  • Chandigarh, India
  • Packiamary Jerome MD
  • Deputy General Superintendent
  • Head of Department of Medicine
  • In charge ICU and RCU
  • Neyveli Lignite Corporation
  • Neyveli, Tamil Nadu, Indiafm9
  • M Ananthi MD
  • Consultant Physician
  • Neyveli Lignite Corporation Hospital
  • Neyveli, Tamil Nadu, India
  • Aman Sharma MD
  • Professor
  • Clinical Immunology and Rheumatology Wing
  • Department of Internal Medicine
  • Postgraduate Institute of Medical
  • Education and Research
  • Chandigarh, India
  • Durga Prasanna Misra MD DM
  • Assistant Professor
  • Department of Clinical Immunology
  • Sanjay Gandhi Postgraduate
  • Institute of Medical Sciences
  • Lucknow, Uttar Pradesh, India
  • Atanu Chandra MD
  • Assistant Professor
  • Department of General Medicine
  • RG Kar Medical College and Hospital
  • Kolkata, West Bengal, India
  • Subhra Sankar Sen MBBS
  • Post Graduate Trainee
  • Department of General Medicine
  • Midnapore Medical College and Hospital
  • Midnapore, West Bengal, India
  • Uddalak Chakraborty MD
  • Senior Resident
  • Department of General Medicine
  • College of Medicine and Sagore Dutta Hospital
  • Kolkata, West Bengal, India
  • Gurleen Wander MD
  • Specialist Registrar
  • Chelsea and Westminster Hospital
  • London, United Kingdom
  • U Meenakshisundaram
  • MD DM
  • Director of Neurology
  • SRM Institutes for Medical Science
  • Chennai, Tamil Nadu, India
  • Jeyaraj Durai Pandian MD DM
  • Principal and Professor of Neurology
  • Christian Medical College
  • Ludhiana, Punjab, Indiafm10
fm11FOREWORD
Siddharth N Shah MD FACP (Hon) FRCP (Edin)
PG Teacher, University of Mumbai
Consultant, Bhatia, SL Raheja
Saifee, and Sir HN Reliance Hospitals
Mumbai, Maharashtra, India
YP Munjal MD MAMS FRCP (Edin)
Medical Director and Honorary Senior Consultant
Diabetes and Life Style Disease Center
Banarsidas Chandiwala Institute of Medical Sciences
New Delhi, India
We are happy to note that the “Year Book of Medicine, 2020 ” is being published by the same group of experts of various subspecialties. It is nice to see it for third year in succession. As in previous years, the authors have picked up landmark articles with good clinical relevance from high-impact medical journals. This comprehensive collection of articles will enable any postgraduate student or practicing physician to get an overview of the new developments in various subspecialties of medicine. The uniformity in the pattern of commentaries, simple expressive language, and associated clinical message are distinguished features of this book. The abstracts of the article tell you the science and evidence on the topic. The commentaries give you an expert's opinion on the interpretation of these trials published in 2019.
In today's era of super specialization, an internist needs to be aware of the latest developments in various fields. This helps us to know what all situations can be handled by a physician and in what situation do we need to refer patients to a superspecialist. Knowledge is power for any physician. It has to be used effectively so that it translates into better clinical practices and patient care. Any activity by a physician is of benefit only if it ends up with better patient management. We urge upon the readers to translate the knowledge acquired from this book into routine clinical use. Physician inertia to adopt newer developments has to be shunned. Interpretation of clinical trials and use of this knowledge for patient care needs discussion among each other. The commentaries by the distinguished editors will be of use in that respect. We live in an era of evidence-based medicine. Medicine is under evaluation and scrutiny more than ever before. Scientifically fm12based patient care with compassion is the best combination. Artificial intelligence, machine learning, and various omics including genomics, metabolomics, and proteomics are all entering into the arena of research and clinical practice. Many studies based on these modern methods have been included in the book. Role of genetics in patient management will increase in the coming years. Diagnostics through wearables and other sensors are now available for better patient- and disease-related information. Electronic medical records (EMRs) will soon be a reality and will become available to us with greater information about the patient's profile and past illnesses. The effort of every student of medicine has to be to acquire the latest knowledge and then use it watchfully for the benefit of the patient. Usually, a single trial will not influence our practices although some large randomized multicentric trials are so highly powered that these change the guidelines for management of some disorders. This book is a comprehensive compilation of all the significant trials of 2019. If one goes through all three “Year Books of 2018, 2019, and 2020”, one will get to know most of the recent developments in medicine and its subspecialties. We hope this exercise will continue in the coming years and we wish good luck to the editors for this scientific activity.
fm13PREFACE
“To study the phenomenon of disease without books is to sail uncharted sea, while to study books without patients is not going to the sea at all.”
– Sir William Osler
We are happy to bring the “Year Book of Medicine, 2020” for the postgraduate students and practicing physicians. This is the third year in succession. You already have the “Year Books of Medicine, 2018 and 2019”. Like the previous years, we have the same 9 sections with an expert in the field as the editor. We are happy that largely it is the same team which started 3 years back. Each section has approx 21 articles from high-impact factor journals and some important Indian journals. Idea is to include those studies which will have a long-term effect on our practice of medicine. A title is given to each commentary, which gives the main message of the trial. The commentary discusses the article and relevant issues. In the end, there are 2–3 key messages, which convey the current evidence-based thinking on the subject.
We have tried to include variety of research articles, which cover the range of each section. The articles chosen have been the choice of the section editor and the sub-editors of that particular section. The chief editor did not make a choice for the other sections. A few review articles have also been included. Only articles, which were published in 2019, have been included in this book. In the previous Year Books 2018 and 2019, we had articles published in 2017 and 2018, respectively. So, in case any library or individual has all three successive Year Books, one can go through a catalog or articles in the last 3 years. This is the only book of its kind in the world. The previous two books were widely read and we had excellent reviews. We have made some improvements based on the suggestions. One major change is that in the editors’ choice, we have summarized 15 articles of 2019, which the section editors did not choose but I still felt that we needed to share that information.
We have all learned a lot in the process of compilation of this book about our and even, the other subspecialties. We hope you will also enjoy reading this book. The abstracts provide the original data and its interpretation is given by the experts in the commentaries. Most abstracts have been published as such after due permission. Wherever we could not get the permissions, we have rewritten them in our own language retaining the main message of the trial.
I have no words to express my gratitude to the editors and the sub-editors who put in so many hours to first choose the articles and then write the commentaries. Mr Jitendar Pal Vij, Group Chairman of Jaypee Brothers Medical Publishers (P) Ltd., has taken personal interest fm14in this book. In fact, it started on his idea only and the format took shape later. It is an honor and a privilege for us to work with him. Dr Richa Saxena, Associate Director (Professional Publishing), is a very capable person, she is also very pleasant to work with. She absorbs a lot of stresses in the process. Her associate Prerna Bajaj (Development Editor) is a very useful member of our team. In my team, Muskan Sharma is the one who coordinates all the activities and without her, this book would not have been possible. We are lucky to have Mr Iqbal with us now who has gelled very well and the trio of us made an enjoyable and productive group.
Since coronavirus disease (COVID-19) came in 2020 only, no article on that is there in this book since all publications started from January 2020. The next Year Book will surely have a lot of articles on COVID-19. Meanwhile, stay safe and enjoy reading the latest information in Medicine.
Gurpreet S Wander